关注
Jennifer Ann Collins
Jennifer Ann Collins
UBC, BCCA, PHSA
在 ubc.ca 的电子邮件经过验证
标题
引用次数
引用次数
年份
Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency
A Brooks-Wilson, M Marcil, SM Clee, LH Zhang, K Roomp, M van Dam, ...
Nature genetics 22 (4), 336-345, 1999
21261999
Mutations in the ABC 1 gene in familial HDL deficiency with defective cholesterol efflux
M Marcil, A Brooks-Wilson, SM Clee, K Roomp, LH Zhang, L Yu, ...
The Lancet 354 (9187), 1341-1346, 1999
4201999
Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes
SM Clee, JJP Kastelein, M van Dam, M Marcil, K Roomp, KY Zwarts, ...
The Journal of clinical investigation 106 (10), 1263-1270, 2000
3932000
CAG expansion in the Huntington disease gene is associated with a specific and targetable predisposing haplogroup
SC Warby, A Montpetit, AR Hayden, JB Carroll, SL Butland, H Visscher, ...
The American Journal of Human Genetics 84 (3), 351-366, 2009
2962009
HTT haplotypes contribute to differences in Huntington disease prevalence between Europe and East Asia
SC Warby, H Visscher, JA Collins, CN Doty, C Carter, SL Butland, ...
European Journal of Human Genetics 19 (5), 561-566, 2011
2042011
Length of uninterrupted CAG, independent of polyglutamine size, results in increased somatic instability, hastening onset of Huntington disease
GEB Wright, JA Collins, C Kay, C McDonald, E Dolzhenko, Q Xia, ...
The American Journal of Human Genetics 104 (6), 1116-1126, 2019
1662019
A SNP in the HTT promoter alters NF-κB binding and is a bidirectional genetic modifier of Huntington disease
K Bečanović, A Nørremølle, SJ Neal, C Kay, JA Collins, D Arenillas, T Lilja, ...
Nature neuroscience 18 (6), 807-816, 2015
1402015
A fully humanized transgenic mouse model of Huntington disease
AL Southwell, SC Warby, JB Carroll, CN Doty, NH Skotte, W Zhang, ...
Human molecular genetics 22 (1), 18-34, 2013
1232013
Huntingtin haplotypes provide prioritized target panels for allele-specific silencing in Huntington disease patients of European ancestry
C Kay, JA Collins, NH Skotte, AL Southwell, SC Warby, NS Caron, ...
Molecular Therapy 23 (11), 1759-1771, 2015
1132015
Ultrasensitive measurement of huntingtin protein in cerebrospinal fluid demonstrates increase with Huntington disease stage and decrease following brain huntingtin suppression
AL Southwell, SEP Smith, TR Davis, NS Caron, EB Villanueva, Y Xie, ...
Scientific reports 5 (1), 1-11, 2015
1102015
Huntington disease reduced penetrance alleles occur at high frequency in the general population
C Kay, JA Collins, Z Miedzybrodzka, SJ Madore, ES Gordon, N Gerry, ...
Neurology 87 (3), 282-288, 2016
1082016
CAG size-specific risk estimates for intermediate allele repeat instability in Huntington disease
A Semaka, C Kay, C Doty, JA Collins, EK Bijlsma, F Richards, ...
Journal of medical genetics 50 (10), 696-703, 2013
952013
The LPL S447X cSNP is associated with decreased blood pressure and plasma triglycerides, and reduced risk of coronary artery disease
SM Clee, O Loubser, J Collins, JJP Kastelein, MR Hayden
Clinical genetics 60 (4), 293-300, 2001
902001
Unstable familial transmissions of Huntington disease alleles with 27–35 CAG repeats (intermediate alleles)
A Semaka, JA Collins, MR Hayden
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 153 …, 2010
812010
Huntington disease in the South African population occurs on diverse and ethnically distinct genetic haplotypes
FK Baine, C Kay, ME Ketelaar, JA Collins, A Semaka, CN Doty, A Krause, ...
European Journal of Human Genetics 21 (10), 1120-1127, 2013
752013
Reduced telomere length variation in healthy oldest old
J Halaschek-Wiener, I Vulto, D Fornika, J Collins, JM Connors, ND Le, ...
Mechanisms of ageing and development 129 (11), 638-641, 2008
742008
The molecular epidemiology of Huntington disease is related to intermediate allele frequency and haplotype in the general population
C Kay, JA Collins, GEB Wright, F Baine, Z Miedzybrodzka, F Aminkeng, ...
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 177 …, 2018
732018
Interrupting sequence variants and age of onset in Huntington's disease: clinical implications and emerging therapies
GEB Wright, HF Black, JA Collins, T Gall-Duncan, NS Caron, CE Pearson, ...
The Lancet Neurology 19 (11), 930-939, 2020
582020
Genetic variation in healthy oldest-old
J Halaschek-Wiener, M Amirabbasi-Beik, N Monfared, M Pieczyk, C Sailer, ...
PLoS One 4 (8), e6641, 2009
562009
High frequency of intermediate alleles on huntington disease‐associated haplotypes in British Columbia's general population
A Semaka, C Kay, CN Doty, JA Collins, N Tam, MR Hayden
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 162 …, 2013
552013
系统目前无法执行此操作,请稍后再试。
文章 1–20